PRAX
Praxis Precision Medicines Inc

1,705
Mkt Cap
$8.69B
Volume
576,993.00
52W High
$326.91
52W Low
$26.70
PE Ratio
-25.11
PRAX Fundamentals
Price
$324.08
Prev Close
$317.25
Open
$307.20
50D MA
$241.61
Beta
0.54
Avg. Volume
848,970.86
EPS (Annual)
-$10.21
P/B
19.97
Rev/Employee
$73,732.76
Loading...
Loading...
News
all
press releases
Nisa Investment Advisors LLC Has $378,000 Stake in Praxis Precision Medicines, Inc. $PRAX
Nisa Investment Advisors LLC boosted its stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 1,033.4% during the 3rd quarter, according to its most recent 13F filing...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Hits New 12-Month High - What's Next?
Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week High - Here's What Happened...
MarketBeat·4d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 7% - Here's Why
Praxis Precision Medicines (NASDAQ:PRAX) Trading 7% Higher - Here's What Happened...
MarketBeat·6d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 6.1% - Here's Why
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 6.1% - What's Next...
MarketBeat·8d ago
News Placeholder
Wedbush Forecasts Strong Price Appreciation for Praxis Precision Medicines (NASDAQ:PRAX) Stock
Wedbush boosted their target price on Praxis Precision Medicines from $83.00 to $95.00 and gave the stock an "underperform" rating in a research report on Monday...
MarketBeat·9d ago
News Placeholder
Praxis Precision Prices $575 Mln Public Offering At $260/shr
(RTTNews) - Praxis Precision Medicines, Inc. (PRAX), a clinical-stage biopharmaceutical company, on Tuesday said it has priced an underwritten public offering of 2.21 million shares of stock at $260...
Nasdaq News: Markets·14d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 3.4% - Here's Why
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 3.4% - Time to Sell...
MarketBeat·21d ago
News Placeholder
Why Praxis Precision Medicines Stock Popped Today
Key PointsMillions of people suffer from movement disorders...
Nasdaq News: Markets·22d ago
News Placeholder
Top Pharmaceutical Stocks To Research - December 29th
Eli Lilly and Company, Novo Nordisk A/S, Pfizer, Ultragenyx Pharmaceutical, Praxis Precision Medicines, AbbVie, and Bristol Myers Squibb are the seven Pharmaceutical stocks to watch today, according...
MarketBeat·22d ago
News Placeholder
Praxis Stock Surges On FDA Breakthrough Status For Essential Tremor Drug
Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.read more...
Benzinga·22d ago
<
1
2
...
>

Latest PRAX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.